13F HOLDINGS REPORT
Merck & Co., Inc.
Quarter ended Q2 2025 · Filed August 13, 2025 · Accession 0001691304-25-000005
Total Value
$215.6M
Positions
13
Other Managers
1
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PERSONALIS INC | PSNL | 14,044,943 | $92.1M | 42.73% |
| 2 | MODERNA INC | MRNA | 2,308,190 | $63.7M | 29.54% |
| 3 | KYMERA THERAPEUTICS INC | KYMR | 772,165 | $33.7M | 15.63% |
| 4 | ENTRADA THERAPEUTICS INC | TRDA | 1,739,768 | $11.7M | 5.42% |
| 5 | ALECTOR INC | ALEC | 3,545,719 | $5.0M | 2.30% |
| 6 | EVAXION BIOTECH A/S | 29970R204 | 1,214,126 | $3.0M | 1.38% |
| 7 | SUTRO BIOPHARMA INC | STRO | 2,723,509 | $1.9M | 0.90% |
| 8 | LAVA THERAPEUTICS NV | N51517105 | 1,149,345 | $1.5M | 0.70% |
| 9 | VIRIDIAN THERAPEUTICS INC | VRDN | 93,414 | $1.3M | 0.61% |
| 10 | XILIO THERAPEUTICS INC | XLO | 1,483,758 | $1.0M | 0.47% |
| 11 | CARISMA THERAPEUTICS INC | CARM | 1,473,240 | $576,921 | 0.27% |
| 12 | NEUPHORIA THERAPEUTICS INC | NEUP | 10,027 | $71,192 | 0.03% |
| 13 | TUHURA BIOSCIENCES | HURA | 13,950 | $31,109 | 0.01% |